<div id="readability-page-1"><p>Bryn Mawr Trust Advisors LLC lessened its holdings in shares of  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,789 shares of the healthcare conglomerate's stock after selling 3,211 shares during the quarter. Bryn Mawr Trust Advisors LLC's holdings in UnitedHealth Group were worth $9,174,000 at the end of the most recent quarter.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill</li></ul><p>Other large investors have also recently modified their holdings of the company. Beacon Financial Strategies CORP purchased a new stake in  UnitedHealth Group during the fourth quarter valued at about $26,000.  Anfield Capital Management LLC raised its position in  UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock valued at $26,000 after purchasing an additional 55 shares in the last quarter.  Joseph Group Capital Management purchased a new stake in  UnitedHealth Group in the fourth quarter worth approximately $27,000.  Foster Dykema Cabot &amp; Partners LLC grew its position in  UnitedHealth Group by 69.4% during the third quarter. Foster Dykema Cabot &amp; Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 34 shares during the last quarter.  Finally, 1248 Management LLC bought a new position in  UnitedHealth Group during the third quarter valued at approximately $29,000. Institutional investors own  87.86% of the company's stock. </p><h2>Insider Buying and Selling at UnitedHealth Group</h2><p>In other news, CEO Patrick Hugh Conway sold 800 shares of the firm's stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. 0.28% of the stock is owned by insiders. </p><h2>UnitedHealth Group Price Performance</h2><ul><li>A  Healthy Rebound Could Lie Ahead for UNH Shareholders</li></ul><p>UNH opened at $379.49 on Friday. The stock has a fifty day simple moving average of $304.54 and a two-hundred day simple moving average of $316.98. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market cap of $344.63 billion, a price-to-earnings ratio of 28.66, a price-to-earnings-growth ratio of 1.64 and a beta of 0.64. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $387.21. </p><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter in the prior year, the company earned $7.20 earnings per share. The firm's quarterly revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS.  Research analysts predict that  UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year. </p><h2>UnitedHealth Group Announces Dividend</h2><ul><li>MarketBeat Week in Review – 01/26 - 01/30</li></ul><p>The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio (DPR) is presently 66.77%. </p><h2>UnitedHealth Group News Summary</h2><p>Here are the key news stories impacting UnitedHealth Group this week:</p><ul>   <li><span>Positive Sentiment: </span>UnitedHealth said it will eliminate prior authorization for 30% of healthcare services, a potentially investor-friendly move that may streamline care and reduce complaints about insurer approvals. <i></i><span>UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services</span></li>   <li><span>Positive Sentiment: </span>Erste Group Bank raised its FY2027 earnings estimate for UnitedHealth, signaling confidence in longer-term profitability, and kept a Buy rating on the stock.</li>   <li><span>Neutral Sentiment: </span>UnitedHealth was highlighted in commentary about value stocks and recovery prospects, which may support investor interest but does not appear to be a direct fundamental catalyst. <i></i><span>UnitedHealth: Watch The Recovery In Action</span></li>   <li><span>Neutral Sentiment: </span>Zacks Research cut near-term and Q4 2027 earnings estimates, which is a headwind, but the revisions were not as central as the company’s policy change and may reflect more cautious forecasting rather than a major deterioration. <i></i><span>Bullish Quarterly Results: 3 Companies Raising Guidance</span></li> </ul><h2>Analyst Ratings Changes</h2><p>UNH has been the topic of a number of recent research reports. Truist Financial  reiterated a &#34;buy&#34; rating and set a $395.00 price target (up from $370.00) on shares of UnitedHealth Group in a research report on Wednesday, April 22nd. Oppenheimer increased their price target on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an &#34;outperform&#34; rating in a research report on Wednesday, April 22nd. Robert W. Baird increased their price target on shares of UnitedHealth Group from $278.00 to $287.00 and gave the company an &#34;underperform&#34; rating in a research report on Wednesday, April 22nd. UBS Group dropped their price objective on UnitedHealth Group from $430.00 to $410.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday, January 28th. Finally, Argus raised UnitedHealth Group from a &#34;hold&#34; rating to a &#34;buy&#34; rating and set a $400.00 price objective for the company in a research note on Wednesday, April 22nd. One research analyst  has rated the stock with a Strong Buy rating, twenty have given a Buy rating, seven have assigned  a Hold rating and one  has given a Sell rating to the company's stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $378.88.</p><p><b>Check Out Our Latest Stock Report on UnitedHealth Group</b></p><h2>UnitedHealth Group Profile</h2> (Free Report)<p>UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.  </p><p>UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due</li><li>Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches</li><li>Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money</li><li>Water Infrastructure: Why This Boring Sector Could Get Exciting</li></ul><p><strong>Want to see what other hedge funds are holding UNH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

UNHG

<p>Bryn Mawr Trust Advisors LLC reduced its stake in UnitedHealth Group (NYSE:UNH) by 10.4% in Q4, holding 27,789 shares valued at $9.17 million. Other investors also adjusted their positions, with institutional ownership at 87.86%. CEO Patrick Hugh Conway sold 800 shares, decreasing his ownership by 4.3%. UnitedHealth reported Q1 earnings of $7.23 per share, exceeding estimates, and announced a quarterly dividend of $2.21 per share. The stock opened at $379.49, with a market cap of $344.63 billion and a P/E ratio of 28.66.</p>

Bryn Mawr Trust Advisors LLC Trims Position in UnitedHealth Group Incorporated $UNH